by Cal Strode | Aug 17, 2022
Launched in June of 2015, ExCellThera is a clinical-stage biotechnology company making strides in developing robust and cost-effective processes for growing blood stem cells for therapeutic use, backed by award-winning proprietary technology. The company was founded...
by Krystal Jacques | Jul 28, 2022
I was telling a friend about how sex determination could be an interesting topic for my next blog and he responded asking, “Don’t we already know everything about sex determination?” So I asked an expert: Dr. Robin Lovell-Badge, the Principal Investigator of a stem...
by Sara M. Nolte | Jul 14, 2022
Almost two years ago, I wrote a post about how scientists were looking for new immunotherapies to improve immunologically “cold” tumours’ responses to existing therapies. And while the findings of that article were very promising, tumour evasion of the immune system...
by Lyla El-Fayomi | Jul 7, 2022
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I sample the latest and greatest findings in recent press and package them into a single post. In this double issue, I cover a gene therapy for...
by Cal Strode | Jun 30, 2022
When I heard that the International Society for Stem Cell Research (ISSCR) was hosting a public symposium to ask if regenerative medicine can turn back the clock on aging, my interest was piqued. The enthusiasm for putting the brakes on aging has been documented as...
by Stacey Johnson | Jun 24, 2022
Long before Bruce Willis’ family announced his aphasia diagnosis to the world, I witnessed the effects of it firsthand through someone in my extended family. Aphasia is characterized by difficulty communicating verbally and in writing, and the most common cause of...
Comments